Methyl 3-amino-2-iodobenzoate

Catalog No.: 
ACWTAV024
CAS No.: 
283173-76-2
Molecular Formula: 
C8H8INO2
Molecular Weight: 
277.06
Methyl 3-amino-2-iodobenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$138.00In stockInquiry
5g95%$487.00In stockInquiry
25g95%$2046.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-amino-2-iodobenzoate
IUPAC Namemethyl 3-amino-2-iodobenzoate
MDL No.MFCD13181905
Molecular FormulaC8H8INO2
Molecular Weight277.06
SMILESO=C(OC)C1=CC=CC(N)=C1I
InChI KeyNDSPWJRSUXVPSQ-UHFFFAOYSA-N
Synonym3-Amino-2-iodobenzoic acid methyl ester;Methyl 3-amino-2-iodobenzoate;Benzoic acid, 3-amino-2-iodo-, methyl ester;Methyl 3-amino-2-iodobenzoate 95%
CAS No.283173-76-2

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301-H317
Precautionary Statement(s)
P280-P301+P310

Synthetic Route by SureRoute

1. ACWTAV024 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRDXJ590 route compound structure diagram
    ACRDXJ59093415-79-3In Stock
  2. Then
  3. ACWTAV024 route product structure diagram
    ACWTAV024283173-76-2In Stock
Inquiry

2. ACWTAV024 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRDXJ590 route compound structure diagram
    ACRDXJ59093415-79-3In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACWTAV024 route product structure diagram
    ACWTAV024283173-76-2In Stock
Inquiry

3. ACWTAV024 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWTAV024 route product structure diagram
    ACWTAV024283173-76-2In Stock
Inquiry

Comments (0)